Research Keyword: CLSI susceptibility testing

Candida vulturna, the Next Fungal Menace? A Narrative Review

Candida vulturna is a newly discovered yeast that causes serious blood infections, particularly in vulnerable patients like premature infants and those with cancer. Though still rare, cases are increasingly appearing in tropical regions with documented hospital outbreaks. While the infection has a better survival rate than related species, it resists several common antifungal drugs, making treatment challenging and requiring careful use of remaining effective medications.

Read More »

Simultaneous infection with Fusarium proliferatum and Prototheca wickerhamii localized at different body sites

An 81-year-old woman taking long-term steroid medication developed two different fungal skin infections on her hands simultaneously – one on the right hand from a moldy wooden frame and one on the left hand possibly from sewage exposure. Doctors identified both fungi through microscopy and genetic testing. She was successfully treated with an antifungal medication called voriconazole for four weeks and recovered completely.

Read More »

Disseminated Scytalidium philadelphianum infection in a Belgian Malinois

A Belgian Malinois dog developed a serious fungal infection caused by Scytalidium philadelphianum, a rare mold, that affected the spine and eventually the brain. The infection was diagnosed through imaging, fluid samples, and fungal culture from the dog’s urine and spine tissue. Despite treatment with multiple antifungal medications over seven months, the dog’s condition worsened with seizures and nerve damage, leading to euthanasia. This case marks the first documented instance of this particular fungal species causing widespread disease in animals.

Read More »
Scroll to Top